Valye reports for unlimited access

RemSleep Holdings Inc. is a medical device company focused on developing and commercializing sleep therapy products, primarily the DeltaWave(TM) CPAP mask and nasal pillow system. The company operates as a smaller reporting entity and trades on the OTCQB market. It has recently completed FDA 510(k) clearance processes and launched its products commercially. Leadership transitioned in early 2026 following the passing of the founder, with Jeffrey Marshall appointed as CEO. The company has engaged in distributor agreements and outlined commercial strategies targeting expanded FDA applications and institutional market entry.

TruGolf Holdings, Inc. is a Nevada-based golf technology company with a history tracing back to Access Software and the Links video game franchise. The company focuses on indoor golf simulation hardware, software, and related services. Its product portfolio includes proprietary launch monitors such as APOGEE and LaunchBox, a range of golf simulator systems from portable to premium custom installations, and software platforms including E6 CONNECT (legacy) and E6 GOLF (next-generation). TruGolf serves residential, commercial, instructional, entertainment, and portable-use markets. The company operates through three main channels: hardware design and sales bundled with software, software licensing, and development of commercial and franchise indoor golf solutions. Market trends show growth in both traditional and off-course golf participation, with increasing demand for simulator-based play and technology-enabled golf venues. TruGolf is expanding its franchise operations and developing digital competition frameworks like the Virtual Golf Association. The company maintains a network of resellers and partners domestically and internationally. It faces competition from integrated hardware/software providers and software-only platforms but leverages its long operating history and integrated platform as competitive strengths.

Premier Air Charter Holdings Inc. operates in the private air charter sector, providing personalized air travel services. The company has been actively expanding its fleet and capabilities through acquisitions of high-performance aircraft such as the Citation X and Challenger 604. It serves markets including Hawaii and Mexico, where it has reported growth. The company engages in capital restructuring activities, including debt conversions to preferred stock, to manage its financial position.

Global Gas Corporation operates as a pure-play hydrogen and carbon recovery project developer and industrial gas supplier. Founded in 2023, the company is building a project development pipeline focused on supplying low-carbon hydrogen, recovered CO2, oxygen, and related industrial gases primarily in North America, Western Europe, and Great Britain. The business model includes sourcing local feedstocks, often renewable waste, and deploying modular generation and recovery equipment close to end customers to reduce distribution costs. Revenue generation is planned through sales of systems and equipment, including electrolyzers and carbon recovery plants, as well as technical and project management services. The company targets customers such as heavy duty fleet operators and industrial gas users. Global Gas faces competition from equipment manufacturers and established industrial gas suppliers. The company has a limited operating history, no significant revenue until recently, and is dependent on raising additional funds and managing regulatory and operational risks [S1,S2].

Texas Ventures Acquisition III Corp is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in July 2024. It has no material operations and was formed to complete a business combination with one or more target companies in any industry. The company completed its initial public offering in April 2025, raising gross proceeds of $225 million by selling units consisting of Class A ordinary shares and warrants. The proceeds are held in a trust account invested in U.S. government securities until a business combination is completed or funds are returned to shareholders. The company has a management team with experience in financial services and transaction execution, which it leverages to identify and evaluate potential acquisition targets. As of the end of 2025, the company had not commenced operations and had no operating revenues. It generates non-operating income from interest on trust account investments. The company is currently engaged in discussions regarding a potential business combination but has not finalized any agreements.

QVC INC is a retailer that markets a broad range of merchandise primarily through television shopping programs and digital platforms including streaming and social media. The company operates internationally, with sales denominated in local currencies outside the U.S. Its business model relies on sourcing and selling consumer products, with exposure to supply chain, tariff, and currency risks. The company reported revenues of $8.29 billion and a net loss of $2.17 billion for fiscal 2025. Liquidity is constrained, with a current ratio below 1.0 and significant near-term debt maturities. The company is actively evaluating refinancing options for its Credit Facility due in October 2026. Credit rating downgrades in 2025 reflect concerns about financial stability and access to capital markets [S1][S2].

BRB Foods Inc. is a Wyoming-incorporated holding company operating in Brazil through its subsidiaries BR Brands S.A. and Boni Logistica Ltda. BR Brands focuses on the development, manufacturing coordination, and commercialization of dry food products, primarily pasta, distributed to wholesalers, supermarkets, and retail chains. Boni Logistica supports logistics coordination and distribution management, utilizing a network of 14 third-party independent distribution centers across Brazil. The company operates a B2B2C business model, selling products to wholesalers and retailers who then sell to end consumers. Historically, BRB Foods commercialized products under intellectual property license agreements with Unilever covering brands such as Arisco, Knorr, Maizena, and Mãe Terra. As of April 2026, three of these license agreements have expired, covering 46 of 61 planned new products, and the remaining Knorr license is set to expire on June 30, 2026. The company suspended revenue-generating activities in Q2 2024 to focus on operational readiness and product portfolio development and has not generated revenue since then. The company's ability to resume commercial activities depends on product readiness, licensing status, market conditions, and capital availability. BRB Foods employs approximately 30 employees in Brazil and has implemented enterprise systems including SAP Business One, WMS, and TMS to support operations.

Ameritek Ventures, Inc. was originally organized in 2010 and transitioned from a software company to a diversified technology holding company by 2025. The company sold its software subsidiaries in late 2024 and acquired Galaxy Batteries, Inc. in 2025, shifting its focus to solid-state batteries, adaptive and robotic manufacturing, aerospace services, and luxury corporate housing. It operates multiple subsidiaries including AeroPass, Inc. and Chicago Real Estate Partners, LLC, which manages furnished luxury condominiums for corporate clients. The company continues to operate DittoMask, Inc. until inventory is sold and plans to divest CordTell, Inc. and WebBeeO, Inc. to an affiliate. Ameritek has also merged with other companies to acquire new products and patents, including augmented reality and robotic technologies.

Nauticus Robotics, Inc. is a technology-driven company specializing in fully electric autonomous subsea robotic solutions. Its product portfolio includes the Aquanaut autonomous underwater vehicle capable of deep-sea operations, the Nauticus ToolKITT software suite enabling autonomous navigation and task execution, and the Olympic Arm electric manipulator designed for complex subsea interventions. The company serves a broad addressable market spanning offshore energy, defense, offshore renewables, subsea mining, and oceanographic research, with a primary focus on oil and gas and defense sectors. Nauticus operates as a single segment with substantial U.S. operations and is expanding internationally. The company faces competition from established ROV manufacturers, software providers, and defense contractors. Nauticus funds its operations through equity offerings, debt facilities, and strategic investments while managing liquidity constraints.

Nature's Miracle Holding Inc. is an agriculture technology company focused on providing Controlled Environment Agriculture (CEA) hardware products to growers in North America. Through its subsidiaries Visiontech Group Inc. and Hydroman, Inc., it supplies grow lights, grow media products, and dehumidifiers for indoor and greenhouse cultivation. The company also facilitates energy rebate solutions linked to LED lighting qualifying for utility rebates. It has developed automated container-sized vertical farms that can match the output of multiple acres of farmland. The company designs mid-to high-end LED and dehumidifier products, sources manufacturing overseas, and distributes from a warehouse in California. Grow media is imported under private label from Europe, India, and other regions. The company primarily serves wholesale distributors and retailers in the U.S. and Canada. In 2025, it generated approximately $1.74 million in revenue but incurred a gross loss and net loss, reflecting ongoing challenges in achieving profitability. The company also owns commercial real estate in Toledo, Ohio, which began generating rental income in late 2025. The business operates in a competitive and fragmented industry with a focus on product quality, brand awareness, and innovation. It faces risks related to supplier concentration, supply chain disruptions, and liquidity constraints [S1].

QVC Group, Inc. operates primarily in the video and online commerce industries through its subsidiaries QVC, Inc., Cornerstone Brands, Inc., and others. Its largest segments include QxH (QVC U.S. and HSN), QVC International, and CBI. QVC is a live social shopping company that markets and sells a broad assortment of consumer products across multiple platforms including television, websites, mobile applications, and social media. The company emphasizes curated, exclusive, and branded merchandise, often endorsed by celebrities, targeting a core demographic of women over 50. QVC Group's operations span North America, Europe, and Asia, with significant distribution infrastructure and a large customer base. The company has recently undergone a name change, a reverse stock split, and is currently in Chapter 11 bankruptcy proceedings, impacting its capital structure and market listing. QVC Group is implementing strategic initiatives such as the WIN strategy to enhance customer engagement and operational efficiency.

My Size, Inc. operates a comprehensive fashion technology platform designed to solve key challenges for fashion brands and retailers: size and fit accuracy, excess inventory, sustainability through circular economy solutions, and international market distribution. The platform integrates four business units: Naiz Fit (AI-driven size and fit SaaS platform), ShoeSize.Me (footwear sizing AI), Orgad (Amazon third-party seller managing over 5,000 SKUs), Percentil (European recommerce platform), and Ten Peacks (brand distribution in Israel). The company’s strategy emphasizes an integrated approach allowing brands to address multiple operational challenges with a single partner, leveraging shared data and commercial synergies. The company pursues growth through expanding U.S. commercial agreements, cross-selling across units, scaling recommerce services driven by EU regulations, technology commercialization, AI platform enhancements, proprietary data asset development, and acquisitions. The company’s financial snapshot as of December 31, 2025, shows modest revenue with net income and liquidity ratios indicating operational capacity but also historical losses and accumulated deficit. The company’s headquarters in Israel expose it to geopolitical risks. Recent acquisitions and formation of subsidiaries support platform expansion and market reach [S1][N1].

Q/C Technologies, Inc. is a technology company that has shifted its business strategy from pharmaceutical development to laser-based computing for blockchain infrastructure, decentralized physical infrastructure networks, and AI-driven high-performance computing. The company leverages an exclusive global license with LightSolver Ltd. to develop and commercialize laser processing units (LPUs), including the qc-LPU100, which aims to provide high computational speed and energy efficiency. The company is currently in early-stage prototype development and benchmarking, with commercialization dependent on successful validation and customer adoption. Legacy pharmaceutical programs, including Isomyosamine and Supera-CBD, remain as reportable segments but are under strategic review for potential divestiture. The company holds a substantial patent portfolio covering both its laser computing and pharmaceutical technologies. Financially, the company reported a net loss of $11.6 million for 2025 and maintains a strong liquidity position with a current ratio of 3.0 as of year-end 2025. The company faces significant competition from established semiconductor and biotech firms, regulatory complexities across multiple jurisdictions, and risks related to capital requirements and intellectual property protection.

ENvue Medical Inc, formerly NanoVibronix, is a Delaware-based medical device company specializing in enteral feeding technologies. Its core product, the ENvue System, is an electromagnetic navigation platform designed to improve the safety and efficiency of feeding tube placement in hospitalized patients. The system is FDA 510(k)-cleared for use in adults and is marketed primarily in the U.S. acute care hospital sector. ENvue's business model combines sales of the navigation system with recurring sales of proprietary disposable feeding tubes and accessories. The company is in the growth phase of commercialization, with multiple hospital engagements and efforts to expand market penetration through direct sales and distribution partnerships. ENvue also develops complementary products and is advancing a robotic platform to automate aspects of feeding tube placement. The company faces competition from other navigation and visualization technologies and operates under regulatory oversight with ongoing clinical and product development activities.

Cytosorbents Corp develops and markets medical devices based on polymer technology, including the CytoSorb cytokine adsorber and other devices such as ECOS-300CY, PuriFi pump, VetResQ, and DrugSorb-ATR. The company’s products target critical care and other medical applications. Regulatory approval and market acceptance are key factors for commercial success. The company is actively engaged in regulatory processes with the FDA and Health Canada for DrugSorb-ATR, including appeals and planned resubmissions. Financially, the company reported a net loss in 2025 and maintains liquidity with a current ratio above 2. The company’s common stock is listed on Nasdaq but has faced minimum bid price compliance issues. The board and executive team have extensive experience in healthcare and medical device sectors.

CirTran Corporation is a contract manufacturer and marketer of consumer products, including tobacco, medical devices, beverages, and licensed adult lifestyle products under the HUSTLER® brand. The company operates through subsidiaries and holds exclusive manufacturing and distribution rights under agreements with licensees such as GloBrands, LLC. CirTran provides end-to-end product development and manufacturing services, leveraging offshore manufacturing partnerships to manage costs and scale production. The company also pursues contract marketing relationships in various consumer product categories and licenses recognized brand names for product commercialization.

Vivakor, Inc. is a Nevada-based integrated midstream energy company providing crude oil transportation, terminaling, marketing, and remediation services primarily in the Permian, Eagle Ford, and Anadarko Basins. The company operates trucking fleets, pipelines including the Omega Gathering Pipeline, and terminaling facilities in Texas and Louisiana. Its marketing and trading segment manages commodity purchases and sales, leveraging its transportation and storage network. The remediation segment is developing a processing center in Texas to recover hydrocarbons from oilfield waste. Vivakor's business model integrates multiple midstream services to capture margin across the crude oil value chain, supported by long-term contracts and strategic acquisitions. The company faces financial challenges including net losses and liquidity constraints but pursues growth through asset optimization and expansion of remediation services [S1].

Mitesco, Inc. was formed in 2012 and has transitioned from operating medical clinics to focusing on data center and cloud computing services. It operates two main subsidiaries: Centcore, providing data center and managed services via co-location agreements and exploring smaller data center formats; and Vero Technology Ventures, developing AI-based cloud applications such as Robo Agent for sales processes. The company has no full-time employees and relies on consultants and directors. It faces competition from established IT service providers and cloud vendors. Mitesco has a history of losses and limited liquidity, with recent efforts focused on financial restructuring and strategic shifts toward technology services.

Drugs Made In America Acquisition Corp. is a Cayman Islands exempted blank check company formed to effect a business combination with one or more target companies. It has no operations or revenue and is classified as a shell company. The company completed its IPO in January 2025, issuing units consisting of ordinary shares and rights, raising gross proceeds of $200 million plus over-allotment and private placement proceeds. The proceeds are held in a trust account invested in U.S. government securities. The company’s strategy is to identify and acquire businesses in AI, pharmaceutical, or other sectors requiring rapid innovation, leveraging its management team's experience and networks. It has established investment criteria focusing on proven industry leaders with defensible business models and growth potential. The company has begun preliminary due diligence on a potential business combination with Power Analytics Global Corp., an enterprise technology platform focused on AI and cybersecurity, but no definitive agreement has been signed. The company has experienced recent management changes and has arranged interim financing to cover expenses related to a business combination. It depends on third-party digital technologies and has limited cybersecurity resources [S1][S2].

Atlantic International Corp. is a company engaged in workforce solutions primarily through its subsidiary Lyneer Staffing Solutions. Lyneer provides staffing services and has integrated AI technologies into its platforms to enhance workforce intelligence and operational efficiency. The company has expanded its business through acquisitions such as Staffing 360 Solutions and Circle8 Group, and has secured contracts with major North American companies. Atlantic International was added to the Russell 3000® Index in mid-2025 and has made key executive appointments to support its operations. Financial disclosures indicate significant net losses and liquidity challenges, with ongoing efforts to restructure substantial joint debt obligations shared with its principal stockholder IDC. The company has also completed a preferred stock offering to support working capital needs.

United Health Products, Inc. specializes in developing, manufacturing, and marketing CelluSTAT, a patented hemostatic gauze derived from cotton. CelluSTAT is FDA-cleared for superficial bleeding and is designed to absorb wound exudate and control bleeding without chemical additives or animal-derived components. The company is actively seeking FDA Premarket Approval for Class III surgical use in the U.S. and CE Mark approval in Europe. The product converts to a translucent gel upon contact with blood, facilitating monitoring of coagulation while maintaining tissue compatibility. Manufacturing is outsourced to FDA-certified suppliers with packaging and sterilization in the U.S. The company holds patents protecting its technology through 2029 and has multiple registered trademarks. United Health Products targets hospitals, surgery centers, EMS, military medical providers, hemodialysis centers, nursing homes, dental offices, and veterinary hospitals as potential customers. The company faces competition from large established wound care companies with greater resources. It has no current revenue and operates at a loss, relying on financing and strategic partnerships to advance its regulatory and commercial objectives.

Mannatech Inc is a publicly traded company incorporated in Texas, United States, with its principal executive offices located in Flower Mound, Texas. The company is listed on the Nasdaq Stock Market under the ticker symbol MTEX. Public disclosures provide limited detail on the company's specific industry classification or product offerings. Financial data from the fiscal year ended December 31, 2025, shows the company experienced a net loss and maintains modest liquidity. Governance structures include board oversight of cybersecurity risks. Recent news highlights include leadership changes, loan extensions with related parties, dividend payments, and quarterly earnings updates indicating variable financial performance.

Nocera, Inc. is a public company listed on Nasdaq under the ticker NCRA, headquartered in New Taipei City, Taiwan. Its business operations focus on two main segments: Fish Trading, conducted through its Taiwan subsidiary, primarily trading eels and planning to expand to other seafood; and E-Commerce, acting as an agent for third-party product sales via live-streaming platforms. The company also provides consulting services for recirculation aquaculture systems (RAS) but discontinued bulk production of RAS units in 2022. It sold its Catering segment interest at the end of 2025. Nocera has made equity investments in e-commerce companies in the U.S. and France. The company owns land in Alabama intended for RAS development but has suspended those plans. It faces regulatory compliance across multiple jurisdictions and operates with a small workforce. Financially, it reported $13.63 million in revenue and a net loss of $2.88 million for 2025, with strong liquidity ratios but ongoing concerns about its ability to continue as a going concern. The company received a Nasdaq deficiency letter in 2026 due to its stock price and is actively addressing compliance.

American Strategic Investment Co., formerly known as New York City REIT, Inc., is an externally managed company owning a portfolio of commercial real estate primarily in Manhattan, New York City. The portfolio consists mainly of office properties and related assets such as retail spaces and parking garages. As of December 31, 2025, the company owned five properties totaling approximately 0.7 million rentable square feet, excluding one property undergoing consensual foreclosure. The company changed its business strategy in late 2022, terminating its REIT election effective January 1, 2023, to broaden the types of assets it may own and operate. The company is managed by New York City Advisors, LLC, and operates as a single reportable segment focused on income-producing properties. The company has faced challenges including occupancy declines, mortgage covenant non-compliance, and liquidity constraints, with ongoing efforts to remediate internal control weaknesses.

LQR House Inc. is a Delaware corporation focused on the alcoholic beverage industry, operating primarily through its wholly owned subsidiaries. Its core business includes the CWSpirits.com e-commerce platform offering a wide range of spirits, wines, and champagnes in the U.S., marketing services targeting the alcohol sector, and the development and marketing of its in-house tequila brand, SWOL Tequila. The company emphasizes direct-to-consumer marketing via social media, influencer networks, and digital campaigns. It maintains strategic partnerships, including exclusive distribution agreements and a key relationship with Country Wine & Spirits, Inc. (CWS), which serves as its sole distributor. LQR House has expanded its footprint through minority investments in wineries and non-alcoholic beverage companies and has engaged in joint ventures for digital content creation, though these were terminated with full return of invested funds. The company has undergone corporate restructuring, including stock splits and increases in authorized shares, and has raised capital through equity offerings. It faces operational risks related to distribution reliance, regulatory compliance, cybersecurity, and capital needs.

CDT Equity Inc. is a Delaware-based pharmaceutical development company that leverages artificial intelligence, solid-form chemistry, and asset repositioning to develop novel therapeutic assets. The company focuses on clinical-stage compounds with strong Phase I safety data, particularly those deprioritized by larger pharmaceutical companies. Its proprietary technologies improve drug properties and extend patent life by up to 20 years. CDT's pipeline includes candidates for autoimmune disorders, idiopathic male infertility, oncology, dermatology, rare diseases, and animal health. The company operates a lean, asset-agnostic model, avoiding the costs of early and late-stage clinical trials by focusing on high-leverage development strategies. Key strategic partnerships include Sarborg Limited, which provides AI-powered signature analysis and decision-support tools, and Manoira Corporation, which collaborates on animal health applications. CDT holds exclusive licenses from AstraZeneca for compounds AZD1656, AZD5658, and AZD5904. The company plans to monetize its assets through licensing and royalty agreements following successful pre-clinical trials. Manufacturing and testing are outsourced to third parties. Financially, CDT reported a net loss of $39.2 million for 2025, with limited liquidity and substantial doubt about its ability to continue as a going concern without additional funding [S1].

Solidion Technology Inc. originated as Nubia Brand International Corp., a special purpose acquisition company formed in 2021, and completed its business combination with Honeycomb Battery Company in February 2024, after which it was renamed Solidion Technology, Inc.[S1][N1]. The company focuses on developing and commercializing advanced battery materials and energy storage solutions, including silicon-rich anode materials, solid-state battery technology, and fire-retardant electrolytes. Its innovations include silane-free and CVD-free silicon anode production methods, elastomer protection technology for silicon particles, biochar-derived anodes with lower carbon footprint, and FireShield™ electrolytes compatible with existing lithium-ion battery manufacturing. Solidion holds a substantial intellectual property portfolio with over 345 active patents globally, supporting its leadership in next-generation battery technologies. The company has strategic partnerships to advance SiOx anode production in the U.S. and leverages global toll manufacturing to scale battery cell production. Financially, as of December 31, 2025, Solidion reported minimal revenue, significant net losses, and liquidity constraints, with a current ratio of 0.04 and cash ratio of 0.01, raising concerns about its going concern status. The company also adopted a Bitcoin allocation policy for its treasury in late 2024.[S1]

Vivos Therapeutics, Inc. develops and markets proprietary oral appliances and therapeutic protocols collectively known as The Vivos Method, designed to non-surgically treat maxillofacial abnormalities associated with obstructive sleep apnea (OSA) and snoring. The company’s products include FDA-cleared devices such as the DNA, mRNA, mmRNA, Vida, and Versa appliances, which are used in combination with adjunctive therapies like myofunctional therapy and chiropractic treatments. Since 2024, Vivos has shifted its business model from primarily training independent dentists to a medical-provider focused approach, acquiring and managing sleep medical practices and establishing Dental and Medical Service Organizations (DSOs and MSOs) branded as Sleep and Airway Medicine Centers (SAMC). This model integrates diagnostics, treatment, and administrative services to expand patient access and revenue streams. The company’s acquisition of The Sleep Center of Nevada (SCN) in 2025 marked a key milestone in this pivot. Vivos also operates The Vivos Institute, a clinical education center for healthcare providers. The company faces operational constraints including limited physical space, provider recruitment, and insurance credentialing delays, but aims to expand through additional acquisitions and strategic alliances.

Allied Energy, Inc. is a Canadian investment holding company focused on technology-enabled businesses, primarily operating through its indirect subsidiary BILI, Inc. BILI offers an AI-powered social commerce platform that enables social media creators to monetize their content by connecting with brands. The platform includes BILI Base™, which allows creators to sell products directly, and BILI Boost™ and BILI Boost+™, which provide AI-enabled marketing campaign services with guaranteed audience engagement metrics. The company targets a broad market including enterprise and small-to-medium brands, commerce creators, and content creators, mainly in North America with some international clients. BILI has established exclusive partnerships with sports organizations to access athlete creators and operates with a lean workforce and asset-light model. The company faces competition from well-capitalized platforms and agencies but leverages AI integration and vertical specialization as differentiators.

Gorilla Technology Group Inc. is a global AI-driven technology company incorporated in 2001 and headquartered in London, UK. It provides advanced solutions in Security Intelligence, Network Intelligence, Business Intelligence, and IoT, serving sectors such as Smart Cities, Government, Enterprise, Manufacturing, Telecommunications, Retail, Transportation, Logistics, Healthcare, and Education. The company integrates AI, deep learning, and edge computing to deliver intelligent video surveillance, facial and license plate recognition, cybersecurity, and network solutions. Gorilla's infrastructure offerings include edge AI devices and datacenter-grade GPU-accelerated platforms, including a GPU-as-a-Service product line. Its consultative sales approach targets multi-year contracts, often with government agencies, involving complex implementations. Gorilla reported $39.3 million revenue and a net loss of $8.5 million for the six months ended June 30, 2025, with a strong current ratio of 2.16. Recent strategic contracts include a $1.4 billion agreement with Freyr Singapore to build AI-powered data centers in Southeast Asia and a $500 million opportunity in India through the Yotta deal. The company emphasizes cybersecurity risk management and compliance with regulatory requirements.

Canaan Inc. operates as a fabless integrated circuit design company specializing in high-performance computing solutions, primarily for the cryptocurrency industry. The company designs and produces Bitcoin mining machines leveraging proprietary ASIC technology and has expanded into the home-use mining machine market with its Avalon Home series. Revenue streams include sales of mining machines and related parts, as well as income from Bitcoin mining operations. The company outsources fabrication and testing to a limited number of third-party foundries and testing partners. Canaan's business performance is influenced by Bitcoin price fluctuations, blockchain technology adoption, product performance, production capacity, research and development investment, and regulatory environment. The company reported significant revenue growth in 2025, reaching $529.7 million, with a gross profit of $41.2 million and a net loss of $210.3 million. Liquidity is supported by cash and current assets exceeding current liabilities, with a current ratio of 3.31 as of December 31, 2025. Canaan's ADSs trade on the Nasdaq Global Market, and the company has received multiple buy recommendations from analysts in late 2025.

BioForce Nanosciences Holdings, Inc. aims to be a provider of natural vitamins, minerals, and nutritional supplements formulated to promote healthier lifestyles for active individuals. The company has not generated revenue in recent years and has no reported sales of its supplement product 'BioForce Eclipse' in 2024 and 2025. It has undergone a reverse stock split in 2020 and has engaged in strategic partnerships, including a memorandum of understanding with Element Global, Inc. in 2021. The company is currently reliant on external financing to continue operations and implement its business plan.

Purebase Corp, headquartered in California, operates through subsidiaries Purebase AG and Purebase AM to develop and market mineral-based agricultural products in the United States. The company produces specialized fertilizers, sun protectants, soil amendments, and bio-stimulants derived from natural minerals such as leonardite and kaolin clay. Its key products include Purebase Shade Advantage WP, a kaolin-clay based sun protectant designed for organic and sustainable crops, and Humic Advantage, a humic acid soil amendment. Distribution is managed through major agricultural distributors and co-ops. The company has discontinued its supplementary cementitious materials (SCM) construction product line to focus on agriculture. Purebase operates under extensive regulatory frameworks governing mining, environmental protection, and agricultural product registration. Financially, the company has reported net losses and working capital deficits, relying on debt and equity financing to support operations. The CEO's ownership of CoreTer LLC, a related party providing financing, presents potential conflicts of interest. The company faces competition from established agricultural product manufacturers and must navigate regulatory compliance costs and market acceptance challenges [S1][S2].

Loan Artificial Intelligence Corp., formerly known as Vestiage, Inc., is a developmental stage company incorporated in Florida in 2006. The company has undergone multiple name changes and business pivots, previously operating in nutraceuticals and fitness event planning before abandoning those operations. Currently, the company is focused on identifying and completing mergers or acquisitions to establish an operating business. It has not yet implemented a business plan and has no definitive agreements for business combinations. The company announced an agreement in October 2025 to acquire Hong Technology Co., Limited, a Hong Kong-based AI technology company, and received audited financial statements for this target in March 2026. The company has no employees as of December 31, 2025, and limited management. Financially, the company reported zero revenue and a net loss of $79,336 for the fiscal year ended December 31, 2025, with minimal liquidity and current liabilities exceeding current assets. The company faces significant competition in sourcing acquisition targets and depends heavily on its management and majority stockholder for strategic decisions. It is subject to U.S. securities regulations and continues to incur operating losses while seeking capital to fund its business plan [S1].

Vystar Corp operates in three primary business areas: Vytex, RxAir, and Fluid Energy Conversion (FEC). Vytex is a patented natural rubber latex technology that reduces allergenic proteins and is used in a wide range of products including medical gloves, condoms, and bedding. RxAir produces FDA-cleared air purification systems using UV light technology that destroys airborne pathogens. FEC focuses on patented green energy technologies involving fluid mechanics. The company previously owned Rotmans Furniture, which ceased operations in 2022. Vystar has partnerships for global distribution of Vytex latex and is engaged in strategic initiatives including acquiring stakes in other companies and launching new platforms. The company faces competition in fragmented markets and operates with a very small workforce.

Veritone, Inc. develops and offers AI computing solutions through its proprietary aiWARE platform, which integrates machine learning algorithms and applications to extract insights from diverse data types. The platform supports commercial enterprises and public sector customers with software products, services, and managed services such as digital content management and content licensing. The company strategically divested its full-service advertising agency business, Veritone One, in October 2024 to concentrate on its core AI software and applications. Veritone operates as a single reportable segment and manages its business on a consolidated basis. The company faces operational challenges including customer concentration and the need to manage debt and liquidity.